Study Finds Similar Heart Risk for Common Painkillers

Cleveland Clinic research suggests celecoxib as safe as other common meds.

0
When the painkiller rofecoxib (Vioxx) was taken off the market in 2004 for patient safety reasons, researchers started looking at the long-term safety of a similar drug: celecoxib (Celebrex). After 10 years of study, Cleveland Clinic researchers have an answer.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access